John A. Stalfort III

Insider Reports History

Entity
Individual
Location
C/O Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville, VA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Stalfort III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Director Common Stock 1.87M $4.61M $2.46 Nov 26, 2024 Direct
Taysha Gene Therapies, Inc. Director Common Stock 1.1M $1.66M $1.51 May 29, 2024 Direct
Taysha Gene Therapies, Inc. Director Common Stock 884K $1.34M $1.51 May 29, 2024 Indirect
Verrica Pharmaceuticals Inc. Director Series A Warrants (right to buy) 562K Nov 22, 2024 Direct
Verrica Pharmaceuticals Inc. Director Series B Warrants (right to buy) 562K Nov 22, 2024 Direct
Taysha Gene Therapies, Inc. Director Stock Option (right to buy) 98.4K May 29, 2024 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 10, 2024 Direct

Insider Reports Filed by John A. Stalfort III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Nov 22, 2024 4 $0 4 Nov 26, 2024 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 10, 2024 Director
TSHA Taysha Gene Therapies, Inc. May 29, 2024 2 $0 4 May 31, 2024 Director
TSHA Taysha Gene Therapies, Inc. Aug 16, 2023 3 $700K 4 Aug 16, 2023 Director
TSHA Taysha Gene Therapies, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
TSHA Taysha Gene Therapies, Inc. Jun 22, 2023 0 $0 3 Jun 26, 2023 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
VRCA Verrica Pharmaceuticals Inc. Jul 5, 2022 1 $500K 4 Jul 5, 2022 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 5 $560K 4 Jul 8, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3/A Jul 8, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director